Skip to main content

NA-1

Drug to Limit Stroke Damage Shows Promise in Human Trials
By Sponsored Health Studies in the News

Drug to Limit Stroke Damage Shows Promise in Human Trials

A new drug called NA-1 developed in Canada is showing a lot of promised in a limited study conducted in Toronto. While the study is a fledgling at phase 2 trials there is a lot of promising proof that offers hope for future stroke victims. The side effects noted in this study were almost non-existent with only […]

Read More about Drug to Limit Stroke Damage Shows Promise in Human Trials

min read